Daniel Ein

1.5k total citations
27 papers, 1.1k citations indexed

About

Daniel Ein is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases. According to data from OpenAlex, Daniel Ein has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Infectious Diseases. Recurrent topics in Daniel Ein's work include Glycosylation and Glycoproteins Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Alzheimer's disease research and treatments (4 papers). Daniel Ein is often cited by papers focused on Glycosylation and Glycoproteins Research (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Alzheimer's disease research and treatments (4 papers). Daniel Ein collaborates with scholars based in United States, Poland and Norway. Daniel Ein's co-authors include George G. Glenner, E. D. Eanes, William D. Terry, Howard A. Bladen, David L. Page, W. Terry, John L. Fahey, Leroy Hood, Shigeru Kimura and Ettore Appella and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Daniel Ein

26 papers receiving 940 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ein United States 16 752 264 217 112 104 27 1.1k
A Morell United States 20 411 0.5× 175 0.7× 122 0.6× 237 2.1× 183 1.8× 56 1.2k
Vera Levytska United States 15 307 0.4× 69 0.3× 87 0.4× 105 0.9× 48 0.5× 17 742
H. G. Schwick Germany 18 338 0.4× 70 0.3× 131 0.6× 224 2.0× 52 0.5× 45 836
J. Donald Smiley United States 17 267 0.4× 73 0.3× 240 1.1× 276 2.5× 64 0.6× 33 1.0k
Zafar I. Randhawa United States 13 533 0.7× 65 0.2× 34 0.2× 155 1.4× 52 0.5× 22 919
T. R. Rutherford United Kingdom 18 682 0.9× 259 1.0× 48 0.2× 143 1.3× 87 0.8× 41 1.4k
H Neda Japan 18 756 1.0× 66 0.3× 144 0.7× 513 4.6× 213 2.0× 45 1.3k
B. Gardner United Kingdom 22 356 0.5× 484 1.8× 255 1.2× 315 2.8× 33 0.3× 40 1.2k
Bruce Rankin United States 12 409 0.5× 55 0.2× 178 0.8× 656 5.9× 116 1.1× 16 1.2k
Daniel Wierda United States 12 296 0.4× 76 0.3× 321 1.5× 470 4.2× 112 1.1× 23 863

Countries citing papers authored by Daniel Ein

Since Specialization
Citations

This map shows the geographic impact of Daniel Ein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ein more than expected).

Fields of papers citing papers by Daniel Ein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ein. The network helps show where Daniel Ein may publish in the future.

Co-authorship network of co-authors of Daniel Ein

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ein. A scholar is included among the top collaborators of Daniel Ein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ein. Daniel Ein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellanti, Joseph A., Bobby Q. Lanier, Daniel Ein, et al.. (2022). The American College of Allergy, Asthma & Immunology: An 80-year legacy of accomplishments (1942-2022), part 3: Events and achievements (2012-2022). Annals of Allergy Asthma & Immunology. 129(4). 528–534. 1 indexed citations
2.
Murphy, Kevin R., Niraj Patel, Daniel Ein, et al.. (2021). Insights from American College of Allergy, Asthma, and Immunology COVID-19 Vaccine Task Force: Allergic Reactions to mRNA SARS-CoV-2 Vaccines. Annals of Allergy Asthma & Immunology. 126(4). 319–320. 21 indexed citations
3.
Marshall, Gailen D., Michael S. Blaiss, Daniel Ein, et al.. (2020). Risk of physician burnout in the North American allergist-immunologist workforce. Annals of Allergy Asthma & Immunology. 125(3). 235–243. 3 indexed citations
4.
Fintzi, Jonathan, et al.. (2020). Asthma is associated with increased risk of intubation but not hospitalization or death in coronavirus disease 2019. Annals of Allergy Asthma & Immunology. 126(1). 93–95. 15 indexed citations
5.
Khan, David A., Aleena Banerji, Jonathan A. Bernstein, et al.. (2019). Cephalosporin Allergy: Current Understanding and Future Challenges. The Journal of Allergy and Clinical Immunology In Practice. 7(7). 2105–2114. 78 indexed citations
6.
Ein, Daniel & Michael B. Foggs. (2014). Accountable Care Organizations and the Allergist: Challenges and Opportunities. The Journal of Allergy and Clinical Immunology In Practice. 2(1). 34–39. 3 indexed citations
7.
Ein, Daniel & Akilah A. Jefferson. (2013). The Patient Protection and Affordable Care Act: causes and effects. Annals of Allergy Asthma & Immunology. 112(1). 6–8. 2 indexed citations
8.
Finegold, Ira, et al.. (2010). Immunotherapy throughout the decades: from Noon to now. Annals of Allergy Asthma & Immunology. 105(5). 328–336. 10 indexed citations
9.
Kelso, John M., James T. Li, Richard A. Nicklas, et al.. (2009). Adverse reactions to vaccines. Annals of Allergy Asthma & Immunology. 103(4). S1–S14. 44 indexed citations
10.
Ein, Daniel, Rebecca S. Gruchalla, James R. Baker, et al.. (2005). Pre-event smallpox vaccination and postevent exposure and disease: a report of the Joint Task Force on Smallpox Vaccination for Allergists. Annals of Allergy Asthma & Immunology. 94(1). 4–7. 1 indexed citations
11.
Ein, Daniel, et al.. (1972). Amino Acid Sequence of an Amyloid Fibril Protein of Unknown Origin. Journal of Biological Chemistry. 247(17). 5653–5655. 93 indexed citations
12.
Isersky, Chaviva, Daniel Ein, David L. Page, Minoru Harada, & George G. Glenner. (1972). Immunochemical Cross-Reactions of Human Amyloid Proteins with Human Immunoglobulin Light Polypeptide Chains. The Journal of Immunology. 108(2). 486–493. 48 indexed citations
13.
Glenner, George G., Daniel Ein, E. D. Eanes, et al.. (1971). Creation of "Amyloid" Fibrils from Bence Jones Proteins in vitro. Science. 174(4010). 712–714. 296 indexed citations
14.
Ein, Daniel, Donald N. Buell, & John L. Fahey. (1969). Biosynthetic And structural studies of a heavy chain disease protein. Journal of Clinical Investigation. 48(4). 785–793. 26 indexed citations
15.
Ein, Daniel & Thomas A. Waldmann. (1969). Metabolic Studies of a Heavy Chain Disease Protein. The Journal of Immunology. 103(2). 345–348. 13 indexed citations
16.
Sanders, Jay H., John L. Fahey, Ira Finegold, et al.. (1969). Multiple anomalous immunoglobulins. The American Journal of Medicine. 47(1). 43–59. 47 indexed citations
17.
Hood, Leroy & Daniel Ein. (1968). Genetic Implications of Common Region Sequence Comparisons of Lambda Immunoglobulin Chains Differing at Position 190. Science. 162(3854). 679–681. 12 indexed citations
18.
Ein, Daniel. (1968). Nonallelic behavior of the Oz groups in human lambda immunoglobulin chains.. Proceedings of the National Academy of Sciences. 60(3). 982–985. 41 indexed citations
19.
Appella, Ettore & Daniel Ein. (1967). Two types of lambda polypeptide chains in human immunoglobulins based on an amino acid substitution at position 190.. Proceedings of the National Academy of Sciences. 57(5). 1449–1454. 59 indexed citations
20.
Ein, Daniel & John L. Fahey. (1967). Two Types Of Lambda Polypeptide Chains In Human Immunoglobulins. Science. 156(3777). 947–948. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A Morell Breakdown of academic impact, for papers by Vera Levytska Breakdown of academic impact, for papers by H. G. Schwick Breakdown of academic impact, for papers by J. Donald Smiley Breakdown of academic impact, for papers by Zafar I. Randhawa Breakdown of academic impact, for papers by T. R. Rutherford Breakdown of academic impact, for papers by H Neda Breakdown of academic impact, for papers by B. Gardner Breakdown of academic impact, for papers by Bruce Rankin Breakdown of academic impact, for papers by Daniel Wierda
Rankless by CCL
2026